| dc.contributor.author | Gurtan, Allan | |
| dc.contributor.author | Goldberg, Michael | |
| dc.coverage.temporal | Spring 2010 | |
| dc.date.accessioned | 2023-03-06T16:39:29Z | |
| dc.date.available | 2023-03-06T16:39:29Z | |
| dc.date.issued | 2010-06 | |
| dc.identifier | 7.346-Spring2010 | |
| dc.identifier.other | 7.346 | |
| dc.identifier.other | IMSCP-MD5-89ba88e2cf7fd6d4ee840dccc6538c2c | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/148316 | |
| dc.description.abstract | Despite centuries of effort, modern medicine still struggles to find the source of disease and to provide specific treatment without side effects. Both traditional small molecules and protein-based therapeutics have achieved only limited success. What is the next therapeutic frontier? The answer may be RNA interference. In this course, we will focus on the therapeutic potential of RNAi. We will discuss its discovery functions in normal biological processes, utility as an experimental tool, potential for therapeutic use, and pursuit by the biotechnology industry. This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. Many instructors of the Advanced Undergraduate Seminars are postdoctoral scientists with a strong interest in teaching. | en |
| dc.language.iso | en-US | |
| dc.rights | This site (c) Massachusetts Institute of Technology 2023. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions. | en |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 Unported | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | * |
| dc.subject | RNAi | en |
| dc.subject | RNA interface | en |
| dc.subject | therapeutics | en |
| dc.subject | siRNA | en |
| dc.subject | miRNA | en |
| dc.subject | shRNA | en |
| dc.title | 7.346 RNAi: A Revolution in Biology and Therapeutics, Spring 2010 | en |
| dc.title.alternative | RNAi: A Revolution in Biology and Therapeutics | en |
| dc.type | Learning Object | |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | |
| dc.audience.educationlevel | Undergraduate | |
| dc.subject.cip | 261001 | en |
| dc.date.updated | 2023-03-06T16:39:35Z | |
